ARGNF:OTCMKTS
argenx SE
$790.15
0.00%
(0.00) 1D
Oct 13, 10:39:58 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGNF...
Mkt. cap
51.38B
Avg. vol.
14.00
Volume
0.00
52-wk high
$1,020.00
52-wk low
$708.72
Beta
0.46
Shares outstanding
62.89M
No. of employees
2K
Mkt. cap
51.38B
Avg. vol.
14.00
Volume
0.00
52-wk high
$1,020.00
52-wk low
$708.72
Beta
0.46
Shares outstanding
62.89M
No. of employees
2K
News stories
From web sources and news partners
ad-hoc-news.de
·
3 hours ago
Wells Fargo sets USD 1,356 target for argenx stock
TipRanks
·
7 hours ago
argenx Schedules Q3 2026 Results Call and Business Update
Pluang
·
7 hours ago
argenx to report Q3 2026 financial results and business update on Oct 22
www.marketscreener.com
·
7 hours ago
Argenx to Report Third Quarter 2026 Financial Results and Business Update on October 22, 2026
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE